Can a daily supplement ease perimenopause? new trial aims to find out
NCT ID NCT07361757
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests three versions of a dietary supplement called Qualia Perimenopause in 120 women aged 40-55 who are experiencing perimenopause symptoms like hot flashes, mood swings, and sleep trouble. Participants take one capsule daily for 28 days and report their symptoms through online questionnaires. The goal is to see if the supplement reduces symptom burden and improves cognitive function and sleep.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Qualia Perimenopause (a multi-botanical dietary supplement)
What this could lead to
If it works, this could provide a natural option to ease common perimenopause symptoms like hot flashes, brain fog, and sleep problems.
What could go wrong
This is a small, early-stage trial with no placebo group, so results may be less reliable. The supplement may not work better than no treatment, and individual results can vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERI-MENOPAUSAL WOMEN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••